Metastatic Colon Cancer Recruiting Phase 2 Trials for Raltitrexed (DB00293)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02618356Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal CancerTreatment